These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14730711)

  • 1. Microglial tau undergoes phosphorylation-independent modification after ischemia.
    Uchihara T; Nakamura A; Arai T; Ikeda K; Tsuchiya K
    Glia; 2004 Jan; 45(2):180-7. PubMed ID: 14730711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible conformational change of tau2 epitope on exposure to detergent in glial cytoplasmic inclusions of multiple system atrophy.
    Shibuya K; Uchihara T; Nakamura A; Ishiyama M; Yamaoka K; Yagishita S; Iwabuchi K; Kosaka K
    Acta Neuropathol; 2003 May; 105(5):508-14. PubMed ID: 12677452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusive induction of tau2 epitope in microglia/macrophages in inflammatory lesions-tautwopathy distinct from degenerative tauopathies.
    Uchihara T; Duyckaerts C; Seilhean D; Nakamura A; Lazarini F; Hauw JJ
    Acta Neuropathol; 2005 Feb; 109(2):159-64. PubMed ID: 15549333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective deposition of 4-repeat tau in cerebral infarcts.
    Ichihara K; Uchihara T; Nakamura A; Suzuki Y; Mizutani T
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1029-36. PubMed ID: 19680140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1997 Mar; 56(3):285-90. PubMed ID: 9056542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
    Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
    Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A semiquantitative study on Alzheimer neurofibrillary tangles demonstrated immunohistochemically with anti-tau antibodies, in the brains of non-demented and demented old people].
    Kuzuhara S; Ihara Y; Toyokura Y; Shimada H
    No To Shinkei; 1989 May; 41(5):465-70. PubMed ID: 2508732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 May; 109(5):483-9. PubMed ID: 15759128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions.
    Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease--comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Shibuya K; Nakamura A; Yagishita S
    Acta Neuropathol; 2005 Mar; 109(3):299-305. PubMed ID: 15619127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction.
    Uchihara T; Tsuchiya K; Nakamura A; Ikeda K
    Neurosci Lett; 2000 Jun; 286(2):99-102. PubMed ID: 10825646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
    Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
    Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
    Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
    Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
    Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion.
    Mailliot C; Podevin-Dimster V; Rosenthal RE; Sergeant N; Delacourte A; Fiskum G; Buée L
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):543-9. PubMed ID: 10724119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
    Williams S; Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
    Barrachina M; Maes T; Buesa C; Ferrer I
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.